Small Biotech Innovation Act

In committee: it can still change before the session ends.

US HR 3731 · House Bill · 119th Congress

What it does

This bill would exempt certain small, research-intensive biotechnology companies from Medicare drug price negotiation starting in 2029.

No official summary is available here. This one was written by AI from the bill’s text.

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

While a bill can still move, the questions are about people and money.

Who sits in the seats that vote on itA roster is not a certified tally, and a filing is not a place on the ballot.
Who funds the people decidingA receipt is not backing. A contribution does not establish a policy motive.
Who is paid to be heardNaming an institution is the filer's account, not a record of any meeting.